ID   COLO/C
AC   CVCL_U289
DR   Wikidata; Q54814180
RX   PubMed=2714338;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).
CC   Derived from metastatic site: Pleural effusion.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens
HI   CVCL_5451 ! COLO 316
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-10-20; Version: 8
//
RX   PubMed=2714338; DOI=10.1016/0277-5379(89)90195-8;
RA   Andrews P.A., Murphy M.P., Howell S.B.;
RT   "Characterization of cisplatin-resistant COLO 316 human ovarian
RT   carcinoma cells.";
RL   Eur. J. Cancer Clin. Oncol. 25:619-625(1989).
//